OCGN stock forecast
Our latest prediction for Ocugen, Inc.'s stock price was made on the Dec. 12, 2019 when the stock price was at 0.35$.
In the short term (2weeks), OCGN's stock price should underperform the market by -2.23%. During that period the price should oscillate between -14.68% and +27.98%.
In the medium term (3months), OCGN's stock price should underperform the market by -15.89%. During that period the price should oscillate between -40.61% and +56.11%.Get email alerts
About Ocugen, Inc.
Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline of therapies includes OCU400, OCU410, OCU200, OCU100, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -12.19$ per share.
The book value per share is -0.82$
Three months stock forecastDec. 12, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|